← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksAMNPrice Target
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

AMN logoAMN Healthcare Services, Inc. (AMN) Price Target Analysis

Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026

Current Price
$20.98
Market reference
Price Target
$22.50
+7.3% Upside
Target Range
$19.50 — $25.00
Moderate consensus
Analyst Rating
Buy
17 analysts
Forward P/E10.3x
Trailing P/E-8.5x
Forward PEG—
Implied Growth+182.4%
Median Target$23.00
Analyst Spread24.4%

AMN trades near analyst consensus with +7.3% potential upside. Limited near-term catalysts may be priced in at current levels.

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$20.98
Consensus$22.50
High$25.00
Low$19.50
Bear Case
$20
-7.0%
Consensus
$23
+7.3%
Bull Case
$25
+19.2%

Analyst Ratings Distribution

Breakdown of 17 published analyst recommendations for AMN

35% hold / mixed conviction
+26
BearishBullish
Weighted analyst sentiment score based on 17 ratings
ConsensusBuy
Coverage17 Analysts
Net Score+26
Bull / Bear59% / 6%
Strong Buy00%
Buy1059%
Hold635%
Sell16%
Strong Sell00%
Strong Buy
00%
Buy
1059%
Hold
635%
Sell
16%
Strong Sell
00%
Recommendation Mix59% Buy · 35% Hold · 6% Sell
Buy (10)Hold (6)Sell (1)

AMN Price Target Analysis

Updated May 7, 2026

As of May 7, 2026, AMN Healthcare Services, Inc. (AMN) has a Wall Street consensus price target of $22.50, based on estimates from 17 covering analysts. With the stock currently trading at $20.98, this represents a potential upside of +7.3%. The company has a market capitalization of $811M.

Analyst price targets range from a low of $19.50 to a high of $25.00, representing a 24% spread in expectations. The median target of $23.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.

The current analyst consensus rating is Buy, with 10 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.

From a valuation perspective, AMN trades at a trailing P/E of -8.5x and forward P/E of 10.3x. Analysts expect EPS to grow +182.4% over the next year.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside+24.4%
Avg Forward P/E25.7x
Peers with Coverage10 / 10
CompanyMarket CapPriceTargetUpsideRatingFwd P/EAnalysts
CHE logoCHEChemed Corporation$5.8B$424.56$475.00+11.9%Hold17.4x9
CCRN logoCCRNCross Country Healthcare, Inc.$326M$10.11$10.61+4.9%Hold103.4x14
TBI logoTBITrueBlue, Inc.$182M$6.05$5.75-5.0%Buy—10
HCSG logoHCSGHealthcare Services Group, Inc.$1.6B$22.07$24.50+11.0%Hold20.6x15
MMS logoMMSMaximus, Inc.$3.5B$63.95$110.00+72.0%Buy7.5x16
OPCH logoOPCHOption Care Health, Inc.$3.2B$20.45$33.00+61.4%Buy11.0x14
ADUS logoADUSAddus HomeCare Corporation$1.8B$96.64$128.67+33.1%Buy14.0x15
ENSG logoENSGThe Ensign Group, Inc.$10.3B$175.93$222.33+26.4%Buy23.4x13
UNH logoUNHUnitedHealth Group Incorporated$333.4B$367.28$385.43+4.9%Buy20.1x52
HCA logoHCAHCA Healthcare, Inc.$96.0B$429.45$527.45+22.8%Buy14.2x46

Upside Potential Comparison

MMS logoMMS
+72.0%
OPCH logoOPCH
+61.4%
ADUS logoADUS
+33.1%
ENSG logoENSG
+26.4%
HCA logoHCA
+22.8%
CHE logoCHE
+11.9%
HCSG logoHCSG
+11.0%
CCRN logoCCRN
+4.9%

See AMN's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is AMN Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare AMN vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

AMN — Frequently Asked Questions

Quick answers to the most common questions about buying AMN stock.

What is the AMN stock price target for 2026?

The consensus price target for AMN is $22.5, close to the current price of $20.975 (7.3% implied move). Based on 17 analyst estimates, the stock appears fairly valued near current levels.

Is AMN a buy, sell, or hold?

AMN has a consensus rating of "Buy" based on 17 Wall Street analysts. The rating breakdown is predominantly bullish, with 10 Buy/Strong Buy ratings. The consensus 12-month price target of $22.5 implies 7.3% upside from current levels.

Is AMN stock overvalued or undervalued?

With a forward P/E of 10.3081x, AMN trades at a relatively low valuation. The consensus target of $22.5 implies 7.3% appreciation, suggesting the market may be pricing in risks.

How high can AMN stock go?

The most bullish Wall Street analyst has a price target of $25 for AMN, while the most conservative target is $19.5. The consensus of $22.5 represents the median expectation. These targets typically reflect 12-month expectations.

How many analysts cover AMN stock?

AMN is well covered by analysts, with 17 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 10 have Buy ratings, 6 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the AMN stock forecast?

The 12-month AMN stock forecast based on 17 Wall Street analysts shows a consensus price target of $22.5, with estimates ranging from $19.5 (bear case) to $25 (bull case). The median consensus rating is "Buy".

What is AMN's forward P/E ratio?

AMN trades at a forward P/E ratio of 10.3x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy AMN stock?

AMN appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $22.5 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do AMN price targets vary so much?

AMN analyst price targets range from $19.5 to $25, a 24% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $22.5 consensus represents the middle ground.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.